Edmund King
Président chez UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.
Profil
Edmund Creighton King is currently the Co-Chairman & Chief Financial Officer at Uniroyal Global Engineered Products, Inc., the Director at Wardle Storeys (Group) Ltd., the Director at Uniroyal Global Ltd., and the General Partner at Trouver Capital Partners LP.
He previously served as the Chairman-Long-Term Care Committee at Healthcare Financial Management Association, Independent Director at LTC Properties, Inc., Director at BioVest International, Inc., Lead Independent Director at Accentia Biopharmaceuticals, Inc., Chief Financial Officer & Director at Flashpoint International, Inc., Chief Financial Officer & Director at SmartPlug, Inc., Partner at Ernst & Young LLP, Senior Healthcare Partner at Arthur Young & Co., and Member at National Association of Corporate Directors (Virginia).
Mr. King obtained his undergraduate degree from Brigham Young University.
Postes actifs de Edmund King
| Sociétés | Poste | Début |
|---|---|---|
| UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC. | Président | 01/01/2007 |
Anciens postes connus de Edmund King
| Sociétés | Poste | Fin |
|---|---|---|
| LTC PROPERTIES, INC. | Directeur/Membre du Conseil | 24/04/2015 |
| ACCENTIA BIOPHARMACEUTICALS INC | Directeur/Membre du Conseil | 04/03/2013 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/10/1991 |
| Healthcare Financial Management Association | Corporate Officer/Principal | - |
Formation de Edmund King
| Brigham Young University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LTC PROPERTIES, INC. | Finance |
| UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC. | Electronic Technology |
| Entreprise privées | 6 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL. | Health Technology |
National Association of Corporate Directors (Virginia)
 National Association of Corporate Directors (Virginia) Miscellaneous Commercial ServicesCommercial Services National Association of Corporate Directors provides online and print information services to directors of public companies. It offers in-boardroom education, evaluation, governance reviews, board composition and succession planning, board recruitment, ongoing advisory, insights, and analytics services. The company was founded in 1977 and is headquartered in Arlington, VA. | Commercial Services |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
| Arthur Young & Co. | Commercial Services |
| Healthcare Financial Management Association |
